Could a common heart drug shrink kaposi sarcoma tumors?

NCT ID NCT05797662

First seen Jan 06, 2026 · Last updated May 14, 2026 · Updated 17 times

Summary

This study tests whether propranolol, a drug usually used for high blood pressure, can treat Kaposi sarcoma. About 25 children and adults with measurable tumors will receive the drug and be monitored for tumor shrinkage and side effects. The goal is to see if this safer, more accessible option can control the disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KAPOSI SARCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • African Cancer Institute at Stellenbosch

    Cape Town, South Africa

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Complexo Hospitalar Universitário Professor Edgard Santos

    Salvador, Brazil

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Fundación Huésped

    Buenos Aires, Argentina

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Instituto Nacional de Cancerologia

    Mexico City, 14080, Mexico

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Instituto Nacional de Câncer José de Alencar

    Rio de Janeiro, 20231-050, Brazil

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Moi University School of Medicine

    Eldoret, Kenya

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • UNC Project Malawi

    Lilongwe, Malawi

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Uganda Cancer Institute

    Kampala, Uganda

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • University of Zimbabwe College of Health Sciences

    Harare, Zimbabwe

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.